Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline + Oral NRT vs Varenicline for Smoking Cessation
NCT03722966Phase 2Terminated
- Sponsor
- University of Oklahoma
- Start
- Jan 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by University of Oklahoma. Started Jan 2020; status: terminated.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03722966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03722966.